Navigation Links
United States Pain Management Report 2017: Focus on Consumer Strategies - Pain Sufferers and Adults who have Selected Illnesses/Conditions - Research and Markets
Date:3/24/2017

DUBLIN, Mar. 24, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Pain Management in the U.S.: Consumer Strategies" report to their offering.

Pain Management in the U.S.: Consumer Strategies focuses on how adults approach and treat their physical pain, emphasizing consumer survey analysis, including trends over time. The report studies two distinct groups: pain sufferers and adults who have selected illnesses/conditions strongly associated with physical pain and pain management. Demographic analysis of these groups is woven into report analysis. Content is further segmented by the nature of consumers' physical pain and chosen pain treatment methods and outcomes.

Key Topics Covered:

Chapter 1: Executive Summary
Pain Ailments And Sufferers
Pain Treatment Management, Methods And Outcomes
Pain Medication

Chapter 2: Introduction And Overview
What Is Pain?
Living With Pain
High Demand For Pain Relief Remedies
Growth In Alternative Therapies

Chapter 3: Pain Ailments And Sufferers
Responding To Pain And Sickness: A Nuanced Approach
Gathering Health Information: Boon And Bane?
Pain-Centric Ailments
Pain Sufferers

Chapter 4: Pain Treatment Management, Methods And Outcomes
Managing Pain
The Role Of Healthcare Practitioners
Treatment Methods And Outcomes
Alternative, Homeopathic And Functional Solutions

Chapter 5: Pain Medication
Taking The Consumers' Pulse On Drug Efficacy, Branding, Packaging And Information
Use Of Medications To Treat Pain-Causing Illness
Vitamins And Supplements
Menstrual Pain

For more information about this report visit http://www.researchandmarkets.com/research/dh7wn6/pain_management

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/united-states-pain-management-report-2017-focus-on-consumer-strategies---pain-sufferers-and-adults-who-have-selected-illnessesconditions---research-and-markets-300429072.html


'/>"/>
SOURCE Research and Markets
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. X-Change Corporation Launches Upgraded Version of Phytiva Website, As Company Targets Distribution of Phytiva Product Line in United States and Worldwide, Extracts and New Products in Europe
2. PharmaPoint: Multiple Sclerosis - United Kingdom Drug Forecast and Market Analysis to 2022
3. ACLS Online Course Manuals are Now Available at No Cost through United Medical Education
4. Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements
5. Following the Successful Launch in the United States, the New Simbionix U/S Mentor to be Introduced for the First Time in Europe
6. Consumer Watchdog: United Healthcare Sued for Discriminating Against HIV/AIDS Patients
7. Misonix, Inc. Announces the Grant of Patent by the United States Patent and Trademark Office
8. Takeda Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States
9. United Medical Credit Hires More Staff to Contact Doctors and Promote their Financing Services
10. Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital
11. Takeda Submits Biologics License Application for a New Investigational Drug Vedolizumab, in Moderately to Severely Active Crohns Disease and Ulcerative Colitis in the United States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017 ... platform, the first non-viral gene expression technology that enables ... the eye to address a wide range of ophthalmic ... Medicines and Healthcare products Regulatory Agency (MHRA) to advance ... ...
(Date:4/19/2017)... April 19, 2017 Cardiology devices segment is anticipated ... The Cardiology Devices segment is likely to create ... Mn in 2018 over 2017. By the end of 2027, ... close to US$ 700 Mn, expanding at a CAGR of ... the Asia Pacific reprocessed medical devices ...
(Date:4/19/2017)... 19, 2017 Global Prostate Cancer Therapeutics ... the prostate cancer therapeutics market analyzes the current ... prevalence of prostate cancer, launch of promising emerging ... of new drugs & therapeutic biological products, and ... to lesser side effects are some of the ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, Texas, ... and which He does not. Yisrayl says with so many titles and names for ... but he says with a little Scripture, backed with a lot of research, the truth ...
(Date:4/28/2017)... ... April 28, 2017 , ... Phytomer USA is ... Côté has 20+ years of experience within the beauty industry, ranging from marketing, ... array of high-end cosmetic brands, retail brands and outlets in Canada and New ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... advanced nutraceutical supplements, through its Nova Skin Sciences division, recently announced the launch ... a moisturizer with the power of an anti-aging concentrate. , Anogeissus ...
(Date:4/28/2017)... ... ... Rob Lowe is a popular actor that has been in many different movies ... as the host of the “Informed” series. The program focuses on many important issues ... focuses on thyroid cancer. , Although thyroid cancer is an uncommon type of cancer, ...
(Date:4/28/2017)... ... ... Christie Medical Holdings, Inc. , with its market-leading vein finder ... a leader in infusion therapy and pain management. , Intravenous (IV) therapy plays ... patients receiving a peripheral IV catheter as part of their treatment plan. Many hospitals ...
Breaking Medicine News(10 mins):